We are live on ! Find out more
AWGLSCP

ABG-WTT Global Life Science Capital Partners Portfolio holdings

AUM $12.3M
1-Year Est. Return 3.13%
This Fund
S&P 500
This Quarter Est. Return
-18.23%
1 Year Est. Return
-3.13%
3 Year Est. Return
+108.96%
5 Year Est. Return
-90.91%
10 Year Est. Return
–
AUM
$12.3M
AUM Growth
-$2.75M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBLL
1
CeriBell Inc
CBLL
$618M
$8.1M 65.87%
441,820
– –
RPID icon
2
Rapid Micro Biosystems
RPID
$99.1M
$4.2M 34.13%
1,848,296
– –

Similar funds

M
MetLife New York $12.3M AUM 29% 1-Year Est. Return
MAMNY
Marathon Asset Management (New York) New York $12M AUM 8.79% 1-Year Est. Return
IWM
Immaculate Wealth Management Mesa, Arizona $12.7M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
PSFG
Park Square Financial Group Roswell, Georgia $13.2M AUM 23.63% 1-Year Est. Return

ABG-WTT Global Life Science Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, ABG-WTT Global Life Science Capital Partners held 2 positions worth $12.3M, down 18% from $15M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 0%. ABG-WTT Global Life Science Capital Partners opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG-WTT Global Life Science Capital Partners's ten largest holdings make up 100% of its $12.3M portfolio in Q1 2026.
  • ABG-WTT Global Life Science Capital Partners opened 0 new positions and closed 0 in Q1 2026.
  • ABG-WTT Global Life Science Capital Partners's portfolio value fell 18% quarter-over-quarter to $12.3M.

Based on ABG-WTT Global Life Science Capital Partners's 13F filing for Q1 2026, filed 18 May 2026.